Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Enigma Biomedical USA, Inc (Enigma) and the University of Wisconsin–Madison (UW–Madison) today announced formation of a partnership focused on development of next-generation Positron Emission Tomography (PET) Imaging and fluid biomarkers. Enigma will support this work at the new Biomarker Development Lab for Age-related Neurodegenerative Disease at the UW School of Medicine and Public Health in Madison, WI. Enigma’s Chief Scientific Officer, Hartmuth Kolb, Ph.D., who serves a visiting Professor at UW–Madison, will collaborate closely with...
   ...more

Ken Notes: OK I ran this story so you would think I was smart enough to know what they were talking about. Bottom line, I am hoping they figure this out before I get Alzheimer`s...